Market open
Cyclacel Pharmaceuticals Inc./$CYCC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
Ticker
$CYCC
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
12
Website
CYCC Metrics
BasicAdvanced
$46M
-
-$2.09
-
-
Price and volume
Market cap
$46M
52-week high
$0.40
52-week low
$0.17
Financial strength
Current ratio
0.586
Quick ratio
0.5
Management effectiveness
Return on assets (TTM)
-116.33%
Return on equity (TTM)
1,431.01%
Valuation
Price to revenue (TTM)
23.456
Price to book
-0.77
Price to tangible book (TTM)
-0.77
Price to free cash flow (TTM)
-0.126
Growth
Revenue change (TTM)
-89.76%
Earnings per share change (TTM)
-92.19%
3-year earnings per share growth (CAGR)
-59.45%
CYCC News
AllArticlesVideos
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
GlobeNewsWire·6 days ago
Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock
GlobeNewsWire·2 weeks ago
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cyclacel Pharmaceuticals Inc. stock?
Cyclacel Pharmaceuticals Inc. (CYCC) has a market cap of $46M as of April 08, 2025.
What is the P/E ratio for Cyclacel Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for Cyclacel Pharmaceuticals Inc. (CYCC) stock is 0 as of April 08, 2025.
Does Cyclacel Pharmaceuticals Inc. stock pay dividends?
No, Cyclacel Pharmaceuticals Inc. (CYCC) stock does not pay dividends to its shareholders as of April 08, 2025.
When is the next Cyclacel Pharmaceuticals Inc. dividend payment date?
Cyclacel Pharmaceuticals Inc. (CYCC) stock does not pay dividends to its shareholders.
What is the beta indicator for Cyclacel Pharmaceuticals Inc.?
Cyclacel Pharmaceuticals Inc. (CYCC) does not currently have a Beta indicator.